CXCL12 and neoplasm: In a prospective trial of 14 patients with NF2 and ipsilateral progressive hearing loss treated with bevacizumab for 12 months, 36% experienced some hearing improvement.31 Elevated blood levels of VEGF-D and stromal cell-derived factor 1⍺ correlated with reduction of tumor size on MRI.